JNJ
JOHNSON & JOHNSONCompany with tickers: JNJ
CIK
200406
CUSIP
478160104
Shares Outstanding
2,408,613,219
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Other | 134 |
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Convert | 4,075 |
| 2026-02-27 | Decker Robert J | VP Corporate Controller | Sell | 4,075 |
| 2026-02-20 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 1,322 |
| 2026-02-20 | Schmid Timothy | EVP, WW Chair, MedTech | Other | 46 |
| 2026-02-18 | Schmid Timothy | EVP, WW Chair, MedTech | Sell | 13,625 |
| 2026-02-18 | Schmid Timothy | EVP, WW Chair, MedTech | Convert | 13,625 |
| 2026-02-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 21,721 |
| 2026-02-17 | Broadhurst Vanessa | EVP, Global Corp Affairs | Sell | 6,197 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Sell | 19,241 |
| 2026-02-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 21,721 |
| 2026-02-17 | Swanson James D. | EVP, CIO | Convert | 20,521 |
| 2026-02-17 | Swanson James D. | EVP, CIO | Sell | 20,521 |
| 2026-02-17 | Wolk Joseph J | Exec VP, CFO | Convert | 19,241 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Convert | 492 |
| 2026-02-15 | Duato Joaquin | Director, CEO and Chairman of the Board | Tax | 1,602 |
| 2026-02-15 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Tax | 816 |
| 2026-02-15 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Convert | 1,594 |
| 2026-02-15 | Broadhurst Vanessa | EVP, Global Corp Affairs | Tax | 252 |
| 2026-02-15 | Broadhurst Vanessa | EVP, Global Corp Affairs | Convert | 492 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Tax | 310 |
| 2026-02-15 | Forminard Elizabeth | EVP, Chief Legal Officer | Convert | 961 |
| 2026-02-15 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Convert | 606 |
| 2026-02-15 | Forminard Elizabeth | EVP, Chief Legal Officer | Tax | 492 |
| 2026-02-15 | Duato Joaquin | Director, CEO and Chairman of the Board | Convert | 3,682 |
| 2026-02-15 | Decker Robert J | VP Corporate Controller | Tax | 94 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Tax | 172 |
| 2026-02-15 | Mulholland Kristen | EVP, Chief HR Officer | Convert | 419 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 1,349 |
| 2026-02-15 | Decker Robert J | VP Corporate Controller | Convert | 339 |
| 2026-02-15 | Schmid Timothy | EVP, WW Chair, MedTech | Convert | 1,028 |
| 2026-02-15 | Schmid Timothy | EVP, WW Chair, MedTech | Tax | 15 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Convert | 1,971 |
| 2026-02-15 | Wolk Joseph J | Exec VP, CFO | Tax | 858 |
| 2026-02-15 | REED JOHN C | EVP, Innovative Medicine, R&D | Tax | 385 |
| 2026-02-15 | Swanson James D. | EVP, CIO | Tax | 214 |
| 2026-02-13 | Schmid Timothy | EVP, WW Chair, MedTech | Tax | 8 |
| 2026-02-13 | Decker Robert J | VP Corporate Controller | Other | 134 |
| 2026-02-13 | Decker Robert J | VP Corporate Controller | Tax | 104 |
| 2026-02-13 | Decker Robert J | VP Corporate Controller | Convert | 312 |
| 2026-02-13 | Schmid Timothy | EVP, WW Chair, MedTech | Other | 745 |
| 2026-02-13 | Schmid Timothy | EVP, WW Chair, MedTech | Convert | 499 |
| 2026-02-13 | Swanson James D. | EVP, CIO | Sell | 19,368 |
| 2026-02-13 | Swanson James D. | EVP, CIO | Tax | 143 |
| 2026-02-13 | Swanson James D. | EVP, CIO | Convert | 447 |
| 2026-02-13 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Tax | 217 |
| 2026-02-13 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Other | 86 |
| 2026-02-13 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Convert | 651 |
| 2026-02-13 | Mulholland Kristen | EVP, Chief HR Officer | Tax | 135 |
| 2026-02-13 | Mulholland Kristen | EVP, Chief HR Officer | Convert | 410 |
| 2026-02-13 | Wolk Joseph J | Exec VP, CFO | Convert | 37,463 |
| 2026-02-13 | Wolk Joseph J | Exec VP, CFO | Tax | 15,948 |
| 2026-02-13 | Wolk Joseph J | Exec VP, CFO | Other | 68,835 |
| 2026-02-13 | Forminard Elizabeth | EVP, Chief Legal Officer | Tax | 314 |
| 2026-02-13 | Forminard Elizabeth | EVP, Chief Legal Officer | Convert | 651 |
| 2026-02-13 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Convert | 1,302 |
| 2026-02-13 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Tax | 409 |
| 2026-02-13 | Duato Joaquin | Director, CEO and Chairman of the Board | Other | 998 |
| 2026-02-13 | Duato Joaquin | Director, CEO and Chairman of the Board | Convert | 3,469 |
| 2026-02-13 | Duato Joaquin | Director, CEO and Chairman of the Board | Tax | 989 |
| 2026-02-13 | Broadhurst Vanessa | EVP, Global Corp Affairs | Convert | 408 |
| 2026-02-13 | Broadhurst Vanessa | EVP, Global Corp Affairs | Tax | 144 |
| 2026-02-06 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Convert | 38,945 |
| 2026-02-06 | Schmid Timothy | EVP, WW Chair, MedTech | Convert | 15,571 |
| 2026-02-06 | Mulholland Kristen | EVP, Chief HR Officer | Convert | 5,625 |
| 2026-02-06 | Mulholland Kristen | EVP, Chief HR Officer | Tax | 3,335 |
| 2026-02-06 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Other | 281 |
| 2026-02-06 | Wengel Kathryn E | EVP, Chief TO and Risk Officer | Tax | 27,270 |
| 2026-02-06 | Schmid Timothy | EVP, WW Chair, MedTech | Tax | 10,335 |
| 2026-02-06 | Schmid Timothy | EVP, WW Chair, MedTech | Other | 745 |
| 2026-02-05 | Forminard Elizabeth | EVP, Chief Legal Officer | Tax | 6,226 |
| 2026-02-05 | Forminard Elizabeth | EVP, Chief Legal Officer | Convert | 8,921 |
| 2026-01-26 | Duato Joaquin | Director, CEO and Chairman of the Board | Sell | 51,218 |
| 2026-01-26 | Duato Joaquin | Director, CEO and Chairman of the Board | Other | 275,967 |
| 2025-11-26 | MORIKIS JOHN G | Director | Buy | 1,250 |
| 2025-11-26 | JOHNSON & JOHNSON | 10% Owner | Sell | 6,337 |
| 2025-11-24 | JOHNSON & JOHNSON | 10% Owner | Sell | 2,200 |
| 2025-11-21 | JOHNSON & JOHNSON | 10% Owner | Sell | 500 |
| 2025-11-12 | JOHNSON & JOHNSON | 10% Owner | Sell | 1,000 |
| 2025-11-07 | JOHNSON & JOHNSON | 10% Owner | Sell | 200 |
| 2025-11-06 | JOHNSON & JOHNSON | 10% Owner | Sell | 52,332 |
| 2025-10-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 21,721 |
| 2025-10-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 21,721 |
| 2025-09-08 | MORIKIS JOHN G | Director | Other | 598 |
| 2025-09-04 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Sell | 56,471 |
| 2025-09-04 | Taubert Jennifer L | EVP, WWC. Innovative Medicine | Convert | 56,471 |
| 2025-08-29 | Forminard Elizabeth | EVP, Chief Legal Officer | Convert | 11,521 |
| 2025-08-29 | Forminard Elizabeth | EVP, Chief Legal Officer | Tax | 9,570 |
| 2025-08-22 | Duato Joaquin | Director, CEO and Chairman of the Board | Sell | 125,824 |
| 2025-08-22 | Duato Joaquin | Director, CEO and Chairman of the Board | Convert | 125,824 |
| 2025-08-22 | Duato Joaquin | Director, CEO and Chairman of the Board | Other | 974 |
| 2025-08-15 | Wolk Joseph J | Exec VP, CFO | Other | 68,835 |
| 2025-08-15 | Wolk Joseph J | Exec VP, CFO | Convert | 16,820 |
| 2025-08-15 | Wolk Joseph J | Exec VP, CFO | Sell | 16,820 |
| 2025-07-17 | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | 19,137 |
| 2025-07-01 | Pinto Daniel E | President & COO | Other | 0 |
| 2025-05-01 | REED JOHN C | EVP, Innovative Medicine, R&D | Tax | 11,002 |
| 2025-05-01 | REED JOHN C | EVP, Innovative Medicine, R&D | Convert | 25,255 |
| 2025-03-18 | Duato Joaquin | Director, CEO and Chairman of the Board | Other | 963 |
| 2025-03-18 | Duato Joaquin | Director, CEO and Chairman of the Board | Gift | 130,852 |